October 2010 Briefing - Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for October 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Pneumonia Vaccination Rate Has Increased in Older Adults
FRIDAY, Oct. 29 (HealthDay News) -- The number of elderly Americans who get vaccinated against pneumonia has increased, but the proportion is still less than 60 percent, and disparities exist among ethnic and racial groups, according to the 2009 National Healthcare Disparities Report, published by the Agency for Healthcare Research and Quality.
CDC: Whooping Cough Vaccine Recommended for Elderly
THURSDAY, Oct. 28 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended that adults aged 65 years and older who are in close contact with infants be vaccinated against whooping cough.
Crizotinib Found to Inhibit Lung Tumor Growth
WEDNESDAY, Oct. 27 (HealthDay News) -- Crizotinib, a small-molecule inhibitor of anaplastic lymphoma kinase (ALK), appears to be effective in reducing or stabilizing lung tumors with ALK rearrangement, according to research published in the Oct. 28 issue of the New England Journal of Medicine.
Primary Care Trails Other Specialties in Hourly Wages
TUESDAY, Oct. 26 (HealthDay News) -- Primary care physicians have substantially lower hourly wages than other specialists, and although most physicians find Medicare reimbursement inequitable, they show little consensus on how to reform it, according to two studies published in the Oct. 25 issue of the Archives of Internal Medicine.
Neuro/Endothelial Effects of Sleep Apnea Coexist in Children
THURSDAY, Oct. 21 (HealthDay News) -- Cognitive dysfunction and endothelial dysfunction usually coexist in children with obstructive sleep apnea syndrome (OSAS), raising the possibility of using the simple measurement of microvascular postischemic reperfusion of the forearm as a screen for cognitive defects as well, according to research published online Oct. 18 in Pediatrics.
Titrated Oxygen Linked to Reduced Mortality in COPD
TUESDAY, Oct. 19 (HealthDay News) -- In patients with chronic obstructive pulmonary disease (COPD), the use of titrated oxygen -- compared to routine high-flow oxygen -- in the prehospital setting is associated with reduced mortality, according to research published online Oct. 19 in BMJ.
New Method Shows Promise for Detecting Lung Cancer
WEDNESDAY, Oct. 13 (HealthDay News) -- The use of partial wave spectroscopic (PWS) microscopy to evaluate cells from the cheek may provide a minimally intrusive screening tool for lung cancer, according to research published online Oct. 5 in Cancer Research.
Anti-PE Benefit Seen From Inferior Vena Cava Filters
FRIDAY, Oct. 8 (HealthDay News) -- The prophylactic use of inferior vena cava filters (IVCFs) appears safe and effective in preventing pulmonary embolism (PE) in patients undergoing major spinal surgery who are at high risk, according to research published in the Sept. 15 issue of Spine.
Mother's Stress Levels Affect Child's Asthma Status
FRIDAY, Oct. 8 (HealthDay News) -- Different types of emotional stress and coping behaviors among mothers may have different impacts on children's asthma status, according to a study published Oct. 7 in BioPsychoSocial Medicine.
Well-Being, Cardiorespiratory Fitness Key to Survival
THURSDAY, Oct. 7 (HealthDay News) -- Low levels of negative emotion and high levels of cardiorespiratory fitness (CRF) are independent predictors of long-term survival, and individuals who have both are at much lower risk of premature death, according to research published in the October issue of the American Journal of Preventive Medicine.
New Insurance Criteria May Adversely Affect Apnea Patients
WEDNESDAY, Oct. 6 (HealthDay News) -- New local coverage determination (LCD) adherence criteria for continued reimbursement of continuous positive airway pressure after 90 days among patients with obstructive sleep apnea may have a negative impact on their clinical care, according to research published in the October issue of Chest.
nCPAP for More Than Two Years Tied to Craniofacial Changes
TUESDAY, Oct. 5 (HealthDay News) -- Adults with obstructive sleep apnea using a nasal continuous positive airway pressure (nCPAP) machine for more than two years may experience significant changes in craniofacial form, according to a study published in the October issue of Chest.